Literature DB >> 21714004

Validation of digital spiral analysis as outcome parameter for clinical trials in essential tremor.

Dietrich Haubenberger1, Daniel Kalowitz, Fatta B Nahab, Camilo Toro, Dominic Ippolito, David A Luckenbaugh, Loretta Wittevrongel, Mark Hallett.   

Abstract

Essential tremor, one of the most prevalent movement disorders, is characterized by kinetic and postural tremor affecting activities of daily living. Spiral drawing is commonly used to visually rate tremor intensity, as part of the routine clinical assessment of tremor and as a tool in clinical trials. We present a strategy to quantify tremor severity from spirals drawn on a digitizing tablet. We validate our method against a well-established visual spiral rating method and compare both methods on their capacity to capture a therapeutic effect, as defined by the change in clinical essential tremor rating scale after an ethanol challenge. Fifty-four Archimedes spirals were drawn using a digitizing tablet by nine ethanol-responsive patients with essential tremor before and at five consecutive time points after the administration of ethanol in a standardized treatment intervention. Quantitative spiral tremor severity was estimated from the velocity tremor peak amplitude after numerical derivation and Fourier transformation of pen-tip positions. In randomly ordered sets, spirals were scored by seven trained raters, using Bain and Findley's 0 to 10 rating scale. Computerized scores correlated with visual ratings (P < 0.0001). The correlation was significant at each time point before and after ethanol (P < 0.005). Quantitative ratings provided better sensitivity than visual rating to capture the effects of an ethanol challenge (P < 0.05). Using a standardized treatment approach, we were able to demonstrate that spirography time-series analysis is a valid, reliable method to document tremor intensity and a more sensitive measure for small effects than currently available visual spiral rating methods.
Copyright © 2011 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21714004      PMCID: PMC4117681          DOI: 10.1002/mds.23808

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  21 in total

1.  Prevalence of essential tremor: door-to-door neurologic exams in Mersin Province, Turkey.

Authors:  O Dogu; S Sevim; H Camdeviren; T Sasmaz; R Bugdayci; M Aral; H Kaleagasi; S Un; E D Louis
Journal:  Neurology       Date:  2003-12-23       Impact factor: 9.910

2.  Open-label dose-escalation study of oral 1-octanol in patients with essential tremor.

Authors:  H A Shill; K O Bushara; Z Mari; M Reich; M Hallett
Journal:  Neurology       Date:  2004-06-22       Impact factor: 9.910

3.  Quantification of tremor with a digitizing tablet.

Authors:  R J Elble; R Sinha; C Higgins
Journal:  J Neurosci Methods       Date:  1990-06       Impact factor: 2.390

4.  Prevalence of essential tremor in three elderly populations of central Spain.

Authors:  Julián Benito-León; Félix Bermejo-Pareja; José-Manuel Morales; Saturio Vega; José-Antonio Molina
Journal:  Mov Disord       Date:  2003-04       Impact factor: 10.338

5.  Spiralometry: computerized assessment of tremor amplitude on the basis of spiral drawing.

Authors:  Peter H Kraus; Arndt Hoffmann
Journal:  Mov Disord       Date:  2010-10-15       Impact factor: 10.338

6.  Assessing tremor severity.

Authors:  P G Bain; L J Findley; P Atchison; M Behari; M Vidailhet; M Gresty; J C Rothwell; P D Thompson; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-08       Impact factor: 10.154

7.  Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial.

Authors:  W Ondo; C Hunter; K D Vuong; K Schwartz; J Jankovic
Journal:  Mov Disord       Date:  2000-07       Impact factor: 10.338

Review 8.  Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee.

Authors:  G Deuschl; P Bain; M Brin
Journal:  Mov Disord       Date:  1998       Impact factor: 10.338

9.  Effect of ethanol on the central oscillator in essential tremor.

Authors:  Kirsten E Zeuner; Fiona M Molloy; Richard O Shoge; Susanne R Goldstein; Robert Wesley; Mark Hallett
Journal:  Mov Disord       Date:  2003-11       Impact factor: 10.338

10.  Pilot trial of 1-octanol in essential tremor.

Authors:  K O Bushara; S R Goldstein; G J Grimes; A H Burstein; M Hallett
Journal:  Neurology       Date:  2004-01-13       Impact factor: 9.910

View more
  36 in total

1.  Alcohol challenge and sensitivity to change of the Essential Tremor Rating Assessment Scale.

Authors:  Bernhard Voller; Emily Lines; Gayle McCrossin; Aaron Artiles; Sule Tinaz; Codrin Lungu; Mark Hallett; Dietrich Haubenberger
Journal:  Mov Disord       Date:  2013-10-07       Impact factor: 10.338

Review 2.  Transducer-based evaluation of tremor.

Authors:  Dietrich Haubenberger; Giovanni Abbruzzese; Peter G Bain; Nin Bajaj; Julián Benito-León; Kailash P Bhatia; Günther Deuschl; Maria João Forjaz; Mark Hallett; Elan D Louis; Kelly E Lyons; Tiago A Mestre; Jan Raethjen; Maria Stamelou; Eng-King Tan; Claudia M Testa; Rodger J Elble
Journal:  Mov Disord       Date:  2016-06-06       Impact factor: 10.338

3.  Octanoic acid suppresses harmaline-induced tremor in mouse model of essential tremor.

Authors:  Fatta B Nahab; Adrian Handforth; Tyler Brown; Christopher Shin; Arnulfo Quesada; Chuanhui Dong; Dietrich Haubenberger; Mark Hallett
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

4.  Tremor in the elderly: Essential and aging-related tremor.

Authors:  Günther Deuschl; Inge Petersen; Delia Lorenz; Kaare Christensen
Journal:  Mov Disord       Date:  2015-06-22       Impact factor: 10.338

5.  The Parkinson's disease e-diary: Developing a clinical and research tool for the digital age.

Authors:  Joaquin A Vizcarra; Álvaro Sánchez-Ferro; Walter Maetzler; Luca Marsili; Lucia Zavala; Anthony E Lang; Pablo Martinez-Martin; Tiago A Mestre; Ralf Reilmann; Jeffrey M Hausdorff; E Ray Dorsey; Serene S Paul; Judith W Dexheimer; Benjamin D Wissel; Rebecca L M Fuller; Paolo Bonato; Ai Huey Tan; Bastiaan R Bloem; Catherine Kopil; Margaret Daeschler; Lauren Bataille; Galit Kleiner; Jesse M Cedarbaum; Jochen Klucken; Aristide Merola; Christopher G Goetz; Glenn T Stebbins; Alberto J Espay
Journal:  Mov Disord       Date:  2019-03-22       Impact factor: 10.338

6.  An open-label, single-dose, crossover study of the pharmacokinetics and metabolism of two oral formulations of 1-octanol in patients with essential tremor.

Authors:  Fatta B Nahab; Loretta Wittevrongel; Dominic Ippolito; Camilo Toro; George J Grimes; Judith Starling; Gopal Potti; Dietrich Haubenberger; Daniel Bowen; Peter Buchwald; Chuanhui Dong; Daniel Kalowitz; Mark Hallett
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

7.  Task-dependent variability of Essential Tremor.

Authors:  Nicole Schuhmayer; Corinna Weber; Markus Kieler; Bernhard Voller; Walter Pirker; Eduard Auff; Dietrich Haubenberger
Journal:  Parkinsonism Relat Disord       Date:  2017-05-20       Impact factor: 4.891

8.  Objective predictors of 'early tolerance' to ventral intermediate nucleus of thalamus deep brain stimulation in essential tremor patients.

Authors:  Shabbir Hussain Merchant; Sheng-Han Kuo; Yu Qiping; Linda Winfield; Guy McKhann; Sameer Sheth; Seth L Pullman; Blair Ford
Journal:  Clin Neurophysiol       Date:  2018-06-05       Impact factor: 3.708

9.  Octanoic acid in alcohol-responsive essential tremor: a randomized controlled study.

Authors:  Dietrich Haubenberger; Gayle McCrossin; Codrin Lungu; Elaine Considine; Camilo Toro; Fatta B Nahab; Sungyoung Auh; Peter Buchwald; George J Grimes; Judith Starling; Gopal Potti; Linda Scheider; Daniel Kalowitz; Daniel Bowen; Andrea Carnie; Mark Hallett
Journal:  Neurology       Date:  2013-02-13       Impact factor: 9.910

Review 10.  The treatment of tremor.

Authors:  Susanne A Schneider; Günther Deuschl
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.